Over The Counter: How To Make An Impact With Your OTC Brand, With PA Consulting’s Rhea Patten

 
• By David Ridley
  
Generate a summary of this article
Listen to this article
Beta

Consumers increasingly demand more from health and wellness brands, particularly valuing those that connect wellness with the home environment, PA Consulting's Rhea Patten explains, in this episode of HBW Insight’s Over the Counter podcast. Consumer health companies also now have a responsibility to contribute to global wellbeing, which can in turn enhance brand impact and drive business growth.

Consumers are expecting more and more from health and wellness brands, PA Consulting’s latest Brand Impact Index shows.

Consumer health brands that link wellness to the sanctuary of the home do particularly well, explains PA associate partner and consumer product expert Rhea Patten, in this episode of HBW Insight’s Over the Counter podcast.

But do consumers expect too much? Do consumer heath companies really have a responsibility to help save the world? Patten says yes, and stresses that doing so will ultimately provide greater opportunities for brand impact and ultimately business growth.

Open Media

Timestamps

1:45 - Introductions

2:40 – Brand Impact Index

8:25 – Why Consumer Health Brands Make An Big Impact

12:00 – The Home As Sanctuary

15:45 – Can Brands Save The World?

20:30 – Eco By Design

26:15 – Greening Your Supply Chain

Guest Bio

Rhea Patten is a consumer product expert at PA Consulting, with expertise in health, beauty, and wellness. She has over 20 years’ experience in leading innovation and transformation projects in the consumer products and retail sector. Passionate about bridging physical products with digital experiences, Rhea helps leaders deliver solutions that drive business growth. She specializes in accelerating product innovation, with a focus on strategy, customer-centricity, and sustainability.

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

SpotifyApple PodcastsWebsite

More from International

Different Name, Same Contamination, Recall Problems For US Homeopathic Nasal Spray Firm

Green Pharmaceuticals’ SnoreStop Nasal Spray, previously marketed as “NasoSpray,” still is available even though agency officials on multiple occasions for a month recommended a recall after an April inspection found “gross microbial contamination” in one lot.

Kratom Industry Argues FDA Wants To Label All Products As Adverse Events Without Evidence

 
• By Malcolm Spicer

Week after publishing safety alert about OPMS Black Liquid Kratom “linked to serious adverse health effects, including death,” FDA announced market research “to understand and characterize emergent risk/safety and perceived benefits reportedly linked to kratom and psychedelics.” But it withdrew the study 10 days later.

ACNU Switch And IND Exemption Final Rules Targeted For October In FDA Regulatory Goals

 
• By Malcolm Spicer

Semi-annual regulatory agenda of non-binding target dates also sets December goal for an NPRM to recognize N-acetyl-L-cysteine as a lawful dietary ingredient. Like IND exemptions rule, item on NAC included for first time in FDA’s list.

‘Inside Regulatory Affairs’ With Kenvue's Kevin Whelan

This HBW Insight series profiles regulatory affairs specialists working in or supporting the consumer health and beauty product industries. In this installment, we speak to Kenvue's Kevin Whelan.

More from Geography

Perrigo Securities Class-Action Settlement Awards Attorneys’ Fees, Expenses Lower Than Requested

 
• By Malcolm Spicer

Court order dismisses claims against Perrigo and Joseph Papa, its former CEO, with prejudice. Settlement also bars any claim against plaintiffs and class members, “whether arising under state, federal, common or foreign law,” alleging liability for losses.

Over The Counter: Exploring The Postbiotic Opportunity In Consumer Health, With Kerry’s Sonja Nodland

 
• By David Ridley

In this episode of the Over the Counter podcast, HBW Insight speaks to Kerry's RDA senior manager of immune and joint health, Sonja Nodland, about the opportunity for innovation that postbiotics represent for the consumer health industry. 

US FDA Adcomm Reform Ideas: Neutral Facilitator As Chair, Public Hearing Lottery Process Tweaks

 
• By Sue Sutter

Proposal to have panelists rate the strength of efficacy and safety evidence on a numeric scale also draws support in written comments on ways to optimize the advisory committee process.